TWST Form 144: Insider Notice to Sell 1,840 Shares ($47,774)

Form 144 filed for Twist Bioscience Corporation (TWST) reporting an intended sale of common stock.

Rhea-AI Filing Summary

Form 144 filed for Twist Bioscience Corporation (TWST) reporting an intended sale of common stock. The notice shows 1,840 shares to be sold through Fidelity Brokerage Services with an aggregate market value of $47,774.13 and an approximate sale date of 08/21/2025. The shares were acquired on 08/20/2025 via restricted stock vesting and relate to compensation. The issuer has 60,360,925 shares outstanding per the form. Recent disposals by the same person, Patrick Finn, are listed: 1,877 shares (05/21/2025, $55,835.87), 209 shares (07/02/2025, $7,564.36), 2,232 shares (07/23/2025, $79,773.02), and 3,189 shares (08/04/2025, $90,453.11).

Insights

Securities Analyst

TL;DR: Routine insider sale from restricted stock vesting; amounts are small relative to outstanding shares and appear non-material.

The filing documents a proposed sale of 1,840 common shares by an insider via a broker, acquired the prior day through restricted stock vesting and characterized as compensation. The form also discloses four prior small sales totaling 7,507 shares over the past three months with disclosed gross proceeds. Compared with the reported 60,360,925 shares outstanding, these transactions represent an immaterial ownership shift and are consistent with typical post-vesting selling activity rather than a company-level development.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signer affirms no undisclosed material information.

The notice includes the required Rule 144 details: acquisition date, nature of acquisition (restricted stock vesting), broker name, and recent sales history for the reporting person, Patrick Finn. The signature/representation language affirms absence of undisclosed material information. There is no indication of a trading plan date on the form, and nothing in this filing signals governance changes or regulatory concerns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is selling TWST shares on this Form 144?

The filing identifies the seller as Patrick Finn, with multiple recent sales and a proposed sale reported on this form.

How many TWST shares are proposed for sale and when?

The notice reports 1,840 common shares to be sold with an approximate sale date of 08/21/2025.

How were the 1,840 shares acquired?

The shares were acquired on 08/20/2025 through restricted stock vesting and the consideration is listed as compensation.

What recent insider sales by the same person are disclosed?

The form lists four prior sales by Patrick Finn in the past three months totaling 7,507 shares on 05/21/2025, 07/02/2025, 07/23/2025, and 08/04/2025 with the corresponding gross proceeds shown.

What is the aggregate market value and shares outstanding reported?

The aggregate market value for the proposed sale is $47,774.13, and the form reports 60,360,925 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2025 - 03:19 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001755970
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	Finn Patrick John
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1840	47774.13	60360925	08/21/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Restricted Stock Vesting	Issuer			1840	08/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	05/21/2025	1877	55835.87
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/02/2025	209	7564.36
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	07/23/2025	2232	79773.02
Patrick Finn 681 Gateway Blvd South San Francisco CA 94080	Common	08/04/2025	3189	90453.11

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Patrick Finn
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)